PeerView Institute

The PeerView Institute is an organization that helps physicians quickly identify science that is Need-to-Know. The 290,000 physician members of the PeerView Institute achieve this goal by using the NTK Science Scoring System^SM and NTK Watch daily email newsletter. These tools enable physicians to rapidly access the most relevant, Need-To-Know information from the myriad medical publications in circulation today.

alendronate
	Determinants of Persistence with Weekly Bisphosphonates in Patients with Osteoporosis -(J Rheumatol)
ciprofloxacin
	Resistance to fluoroquinolones and treatment failure/short-term relapse of community-acquired urinary tract infections caused by Escherichia coli -(J Infect)
clopidogrel
	Very late stent thrombosis after discontinuation of clopidogrel therapy -(Med J Aust)
	Post-PCI fatal bleeding in aspirin and clopidogrel hyper responder Shifting from antiplatelet resistance to bleeding risk assessment? -(Int J Cardiol)
	Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (On-TIME 2): a multicentre, double-blind, randomised controlled trial -(Lancet)
	Clopidogrel and bleeding after general surgery procedures -(Am Surg)